High HDL causes: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
|||
| Line 201: | Line 201: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Lipoproteins]] | [[Category:Lipoproteins]] | ||
[[Category:HDLpedia]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 14:16, 21 October 2013
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
High HDL causes On the Web |
|
American Roentgen Ray Society Images of High HDL causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The causes of an increased HDL cholesterol is centered around therapeutic measures aimed at treating low levels of HDL-C which is associated with a poor cardiovascular outcome. These measures may involve life-style modifications (e.g., aerobic exercises, weight loss, smoking cessation, consumption of dietary fibers) or with the use of medications (e.g., fibrates, niacin, statins). However, genetic factors which affect the catabolism of HDLs have also been implicated, for example, cholesteryl ester transfer protein (CETP) deficiency and familial hyperalphalipoproteinemia or hepatic lipase deficiency.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
High HDL does not have any life-threatening cause.
Common Causes
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | Benign symmetrical lipomatosis |
| Dermatologic | No underlying causes |
| Drug Effect | Anacetrapib, apoA-1 Milano, cannabis, CER-001, CSL-112, dalcetrapib,doxazosin, estrogen, fibrate, lovaza, moderate alcohol consumption, niacin, prazosin, statins, torcetrapib |
| Drug Side Effect | No underlying causes |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | Liver cirrhosis, primary biliary cirrhosis |
| Genetic | Benign symmetrical lipomatosis, cholesteryl ester transfer protein (CETP) deficiency, familial hyperalphalipoproteinemia or hepatic lipase deficiency |
| Hematologic | No underlying causes |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | Caprylic acid, decanoic acid, dietary fiber, hexanoic acid , lauric acid, magnesium, omega-3 fatty acid, unsaturated fat |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | Anorexia nervosa |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | Primary biliary cirrhosis |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | Aerobic exercise, excessive weight loss, smoking cessation |